leading scientists with the "Human Genome Project."
"The formation of febit's scientific advisory board brings together key thought leaders with deep insight into the needs of the scientific community in genomic research," said Cord F. Staehler, CEO of febit holding gmbh. "We look forward to their support and guidance that will help us realize the full potential of febit's portfolio of unique applications for existing and future strategic partnerships."
Dr. Chee added, "It is our goal to help febit meet scientists' needs and open up new possibilities in genomic research. febit's Geniom technology is a unique tool for various applications in this field from microarray analysis to synthetic biology."
febit enables scientists to read, write and understand the code of
life: DNA. With its unique Geniom technology and services, febit is the
only company that puts the control of simplified genomic research in the
hand of the user. The seamless integration of DNA synthesis and analysis
and the superior support in experiment design and bioinformatics helps to
understand data and turn it into results. febit's team of experienced
scientists is dedicated to support customers to solve the challenge of
understanding biological processes. Geniom is a technological and service
platform successfully implemented in basic and applied research by renowned
institutions and companies. Geniom exploits cutting-edge microarray
technology for analysis and synthesis of genes and genomes, providing
superior time- and cost-efficiency combined with an unsurpassed spectrum of
febit holding gmbh Russo Partners, LLC
Eva Sterzel David Schull or Wendy Lau
Public Relations Manager +1-212-845-4271
|Copyright©2008 PR Newswire.|
All rights reserved